Limited duration of complete remission on ruxolitinib in myeloid neoplasms with PCM1-JAK2 and BCR-JAK2 fusion genes

201479 citationsJournal Article

Authors

Good health and well-being

Published in: Annals of Hematology

Volume 94, Issue 2, pp. 233-238

Field-Weighted Citation Impact: 3.98